Skip to main content
. Author manuscript; available in PMC: 2021 May 26.
Published in final edited form as: J Integr Cardiol. 2018 May 22;4(3):10.15761/jic.1000246. doi: 10.15761/jic.1000246

Table 1.

Baseline characteristics of the Multi-Ethnic Study of Atherosclerosis (MESA) participants by baseline Chronic Kidney Disease (CKD) Status

Total (n=5,504) CKD (n=325) Non-CKD (n=5,179) *P-value
Age (years) 62.3±10.3 73.0±8.0 61.6±10.1 <0.001
Sex (Male) 48.6% 43.1% 48.9% 0.04
Black 24.1% 22.8% 24.2% 0.6
White 39.4% 45.2% 39.0% <0.001
Hispanic 23.1% 19.4% 23.4% 0.1
Chinese 13.4% 12.6% 13.5% 0.7
Smoking 12.6% 8.3% 12.9% 0.02
BMI (kg/m2) 28.2±5.4 28.5±5.4 28.2±5.4 0.3
Diabetes Mellitus 13.2% 19.9% 12.6% <0.001
Heart rate (beats per minute) 63.1±9.7 63.6±11.2 63.1±9.6 0.3
SBP (mmHg) 126±21.4 139±25.0 126±20.9 <0.001
Hypertension 44.2% 78.2% 42.1% <0.001
Blood pressure medication use 32.6% 64.6% 30.6% <0.001
LDL (mg/dL) 117±31.4 116±33.5 117±31.2 0.74
HDL (mg/dL) 50.8±14.8 49.6±15.0 50.9±14.8 0.1
Cholesterol (mg/dL) 194±35.9 196±41.4 194±35.5 0.3
Lipid lowering medication use 16.1% 27.4% 15.4% <0.001
NT-proBNP (pg/mL) 50.7 (49.1, 52.3) 158.0 (140, 178) 47.2 (45.8, 48.7) <0.001
Cystatin C (mg/L) 0.90±0.25 1.49±0.60 0.86±0.15 <0.001
Creatinine (mg/dL) 0.84±0.29 1.33±0.80 0.81±0.17 <0.001
Creatinine-cystatin C eGFR (mL/min/1.73m2) 89.8±18.4 48.8±11.0 92.4±15.5 <0.001
Heart failure 219 (3.98%) 39 (12.0%) 180 (3.48%) <0.001

Data presented as mean ± standard deviation or frequency (%) unless otherwise noted.

*

P-values compare CKD with Non-CKD groups. Abbreviations: CKD = chronic kidney disease; BMI = body mass index; SBP = systolic blood pressure; LDL = low-density lipoprotein; HDL = high-density lipoprotein;

NT-proBNP = N-terminal pro-brain natriuretic peptide shown as geometric mean (95% CI); eGFR = estimated glomerular filtration rate based on serum creatinine and cystatin C levels [28]. CKD defined as eGFR < 60 ml/min/1.73m2.